Cargando…
Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer
BACKGROUND: We performed a retrospective analysis to determine the incidence of neurotrophic tropomyosin-receptor kinase (NTRK) fusion in non-small cell lung cancer (NSCLC). METHODS: Archival NSCLC tissues between 2018–2020 were screened by immunohistochemistry (IHC) with IHC-positive cases undergoi...
Autores principales: | Poh, Ashleigh, Sammour, Abdelaziz, Mathai, Jared, Peverall, Joanne, Van Vliet, Chris, Asadi, Khashayar, Parakh, Sagun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407491/ https://www.ncbi.nlm.nih.gov/pubmed/37559603 http://dx.doi.org/10.21037/jtd-23-113 |
Ejemplares similares
-
Real-World Experience of NTRK Fusion–Positive Thyroid Cancer
por: Park, Jong Chul, et al.
Publicado: (2022) -
Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy
por: Wang, Yang, et al.
Publicado: (2023) -
Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
por: Parakh, Sagun, et al.
Publicado: (2021) -
Editorial: Overcoming drug relapse and therapy resistance in NSCLC
por: Parakh, Sagun, et al.
Publicado: (2023) -
NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
por: Siozopoulou, Vasiliki, et al.
Publicado: (2021)